Beckman Coulter, Inc.
Beckman Coulter, Inc., a leading name in the life sciences and diagnostics industry, is headquartered in the United States. Founded in 1935, the company has established itself as a pioneer in laboratory instrumentation and reagents, focusing on areas such as clinical diagnostics and research. With a strong presence in North America, Europe, and Asia, Beckman Coulter is renowned for its innovative solutions that enhance laboratory efficiency and accuracy. The company’s core products include advanced analyzers and diagnostic systems, which are distinguished by their precision and reliability. Beckman Coulter's commitment to quality has positioned it as a trusted partner in healthcare, contributing to significant advancements in patient care. Notable achievements include numerous awards for innovation and excellence, solidifying its status as a market leader in the diagnostics sector.
DitchCarbon Score
How does Beckman Coulter, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beckman Coulter, Inc.'s score of 35 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beckman Coulter, Inc.'s reported carbon emissions
Beckman Coulter, Inc., headquartered in the US, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2023 as the baseline year. This commitment aligns with the Science Based Targets initiative (SBTi) and is designed to support global efforts to limit warming to 1.5°C. In addition to its direct emissions (Scope 1 and 2), Beckman Coulter is also focused on measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. The company’s targets reflect a strong commitment to sustainability and responsible environmental stewardship, positioning it as a proactive player in the healthcare and diagnostics industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beckman Coulter, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
